Skip to main content
. 2011 Jan 10;29(8):1014–1021. doi: 10.1200/JCO.2009.27.6543

Table 3.

pCR Rates by Disease Subtype, Receptor Status, Stage, and Treatment Arm

Variable Standard Arm
Continuous Arm
Total
P
No.* % No.* % No.* %
Overall .45
    pCR 37/179 20.7 43/177 24.3 80/356 22.5
    No pCR or no surgery 142/179 79.3 134/177 75.7 276/356 77.5
Inflammatory breast cancer .06
    pCR 7/56 12.5 15/55 27.3 22/111 19.8
    No pCR or no surgery 49/56 87.5 40/55 72.7 88/111 80.2
Locally advanced breast cancer .88
    pCR 30/123 24.4 28/122 23.0 58/245 23.7
    No pCR or no surgery 93/123 75.6 94/122 77.0 187/245 76.3
Receptor-negative breast cancer .40
    pCR 25/86 29.0 26/73 35.6 51/159 32.1
    No pCR or no surgery 61/86 71.0 47/73 64.4 108/159 67.9
Receptor-positive breast cancer .39
    pCR 9/84 10.7 15/98 15.3 24/182 13.2
    No pCR or no surgery 75/84 89.3 83/98 84.7 158/182 86.8
Stage IIB .23
    pCR 13/35 37.1 4/21 19.1 17/56 30.4
    No pCR or no surgery 22/35 62.9 17/21 80.9 39/56 59.6
Stage IIIA .67
    pCR 16/54 29.6 14/56 25.0 30/110 27.3
    No pCR or no surgery 38/54 70.4 42/56 75.0 80/110 72.7
Stage IIIB .0057
    pCR 8/86 9.3 24/93 25.8 32/179 17.9
    No pCR or no surgery 78/86 90.7 69/93 74.2 147/179 82.1

Abbreviation: pCR, pathologic complete response.

*

No. refers to No. achieving indicated result (pCR v no pCR) over total evaluated for this end point.

All P values are two sided.